Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
出版年份 2021 全文链接
标题
Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
作者
关键词
-
出版物
JCI Insight
Volume 6, Issue 8, Pages -
出版商
American Society for Clinical Investigation
发表日期
2021-03-17
DOI
10.1172/jci.insight.146827
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer
- (2020) Siyuan Cheng et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors
- (2020) Yezi Zhu et al. ONCOGENE
- LSD1: A single target to combat lineage plasticity in lethal prostate cancer
- (2018) Leigh Ellis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
- (2018) Yan Zhang et al. Nature Communications
- Evolving concepts in prostatic neuroendocrine manifestations: from focal divergent differentiation to AMPHICRINE carcinoma
- (2018) Shubha Bellur et al. HUMAN PATHOLOGY
- HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer
- (2018) Dorhyun Johng et al. PROSTATE
- Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage
- (2018) Jung Wook Park et al. SCIENCE
- Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin?
- (2017) Susan Prendeville et al. HISTOPATHOLOGY
- LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics
- (2017) Holly M. Nguyen et al. PROSTATE
- Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1
- (2017) Mayuko Kanayama et al. PROSTATE
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
- (2017) Sheng Yu Ku et al. SCIENCE
- Multipotent Basal Stem Cells, Maintained in Localized Proximal Niches, Support Directed Long-Ranging Epithelial Flows in Human Prostates
- (2017) Mohammad Moad et al. Cell Reports
- Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer
- (2016) Y. C. Yang et al. CLINICAL CANCER RESEARCH
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein
- (2016) Shuai Gao et al. Cell Reports
- SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
- (2015) X. Zhang et al. CLINICAL CANCER RESEARCH
- Engineering Enzymatically Activated “Molecular Grenades” for Cancer
- (2015) Samuel R. Denmeade et al. Oncotarget
- Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation
- (2014) Donald J. Vander Griend et al. International Journal of Biological Sciences
- Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis—A Systematic Review and Pooled Analysis
- (2014) Hai Tao Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition ofc-MYCtranscription
- (2014) Lizamma Antony et al. PROSTATE
- SOX2 expression in the developing, adult, as well as, diseased prostate
- (2014) X Yu et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Tracking the clonal origin of lethal prostate cancer
- (2013) Michael C. Haffner et al. JOURNAL OF CLINICAL INVESTIGATION
- p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia
- (2013) J.-C. Pignon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Carcinoma-Associated Fibroblasts Within the Tumor Stroma With a Fibroblast Activation Protein-Activated Prodrug
- (2012) W. N. Brennen et al. JNCI-Journal of the National Cancer Institute
- Germline Mutations inHOXB13and Prostate-Cancer Risk
- (2012) Charles M. Ewing et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer
- (2012) John T. Isaacs et al. PROSTATE
- Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer
- (2011) Gerhardt Attard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
- (2011) M. J. Evans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
- (2011) H. Beltran et al. Cancer Discovery
- NKX3.1 as a Marker of Prostatic Origin in Metastatic Tumors
- (2010) Bora Gurel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Identification of a Cell of Origin for Human Prostate Cancer
- (2010) A. S. Goldstein et al. SCIENCE
- A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland
- (2009) R. P. McMullin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiation
- (2008) D. E. Frigo et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now